Picture of Celularity logo

CELU — Celularity News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapNeutral

Celularity Inc reports results for the quarter ended in June - Earnings Summary

* Celularity Inc  CELU.OQ  reported a quarterly adjusted loss of
$2.69​​ per share for the quarter ended in June. The lone
analyst forecast for the quarter was for a loss of 16 cents per
share.
* Revenue was $3.20 million​;  analysts expected zero. 
* Celularity Inc's reported EPS for the quarter was a loss of
$2.69​.
* The mean earnings estimate of analysts had fallen by
about 6.7% in the last three months.​ 
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
* Celularity Inc shares had fallen by 36.1% this quarter and
lost 40.9% so far this year.
* The company reported a quarterly loss of $64.48 million.
* Wall Street's median 12-month price target for Celularity Inc
is $16.00 
* The current average analyst rating on the shares is "strong
buy" and the breakdown of recommendations is 1 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell." 
This summary was machine generated August 16 at 11:15 p.m.  ​All
figures in US dollars unless otherwise stated

Recent news on Celularity

See all news